novo nordisk semaglutide patent Expiry Day: India MD On How Company Plans To Defend Its Dominance Off-patent semaglutide in 2026: the

Heres what you need to know: Manufacturer Savings Programs Novo Nordisk (makes Wegovy, Ozempic, and Saxenda) offers savings cards that can reduce copays to as low as $25 per month for eligible patients with commercial insurance These programs have specific eligibility requirements and typically exclude Medicare/Medicaid patients Your doctors office can help you determine eligibility and apply Prior Authorization Tips If your insurance requires prior authorization, be patient

Weight Loss Results: Semaglutide vs

Patients should report persistent stool changes to their GP, particularly if accompanied by abdominal pain, as GLP-1 therapy carries rare risks of pancreatitis and gallbladder disease

It's imperative that those living with obesity receive the support and care they rightly deserve," said Priti Chawla, Executive Director of Obesity Matters in a press release

4 patients (0.2 cases per 100 patient-years) receiving placebo

Reassess at 8 weeks